Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tymlos Inclusion Stands Out As Express Scripts Reveals 2018 Formulary

Aug 01 2017

• By Mandy Jackson

Syringes stuck in a dartboard

Related Content

Keeping Track: Trulance Is First Novel Drug Of 2017; Vantrela ER Is Year's Second Abuse-Deterrent Opioid

Jan 22 2017

Sanofi/Regeneron Choose Access Over Price With Dupixent Launch

Mar 28 2017

Roche Set For Disruptive Entry To MS Market With 'Brave' Ocrevus Pricing Strategy

Mar 29 2017

EpiPen Competitor Auvi-Q Relauching With Ultimate Copay: $0

Jan 20 2017

Opana ER Withdrawal Adds Weight To Endo's Ongoing Revenue Decline

Jul 07 2017

Will Radius Health's Abaloparatide Data Do The Trick In Osteoporosis?

Aug 19 2016

Teva’s 'Key Ingredient' For Growth: Biosimilars

Sep 13 2016

Related Companies

Express Scripts Holding Company

Radius Health, Inc.

Eli Lilly and Company

Sanofi

Regeneron Pharmaceuticals, Inc.

Roche Holding AG

Genentech, Inc.

Merck KGaA

Ironwood Pharmaceuticals, Inc.

Allergan plc

Mallinckrodt plc

Synergy Pharmaceuticals, Inc.

Amgen, Inc.

Teva Pharmaceutical Industries Ltd.

Novartis AG

Novartis AG

Viatris Inc.

Kaléo Pharmaceutical Inc.

Endo, Inc.

Assertio Holdings, Inc.

Purdue Pharma L.P.

Additional Topics

Market Access Pricing Strategies Reimbursement Commercial BioPharmaceutical

More from Drug Pricing

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window